Europe — EMA

Olmesartan Medoxomilo Aurovitas

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomilo Aurovitas, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to manage high blood pressure in adult patients. GNH USA supplies Olmesartan Medoxomilo Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomilo Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan medoxil is an angiotensin II receptor antagonist indicated for several cardiovascular conditions.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: used as part of combination therapy to improve symptoms and outcomes. - Diabetic nephropathy: helps slow progression of kidney damage associated with diabetes.

What are the side effects of Olmesartan Medoxomil?

Olmesartan medoxil provides ... ....

What precautions apply to Olmesartan Medoxomil?

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →